{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:18:56Z","timestamp":1794377936812,"version":"4.9.0"},"reference-count":147,"publisher":"Bentham Science Publishers Ltd.","issue":"41","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Infection remains a significant global health concern, with millions of\nnew cases and deaths occurring due to infectious diseases. Currently, chemoprophylaxis and\nchemotherapy are the primary treatments, but side effects and toxicities pose challenges. Pathogenic\nmicroorganisms have developed resistance to antimicrobial medications. Nitrogen containing\nheterocyclic scaffolds possess the potential in drug discovery and are explored in various\nfields like pharmaceuticals, cosmetics, and agrochemicals. To minimize antimicrobial drug\nresistance, there is a need to design potent, safer antimicrobial lead compounds with higher selectivity\nand minimal cytotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The present review aims to outline several recent developments in medicinal\nchemistry aspect of nitrogenous heterocyclic derivatives with the following purposes: (1) To\ncast light on the recent literature reports of the last eight years ranging from 2015 to 2023 describing\nanti-microbial potential of nitrogen-containing heterocyclic derivatives which includes\npyrazole, pyrazoline, imidazole, tetrazole and quinoline; (2) To brief the recent developments\nin the medicinal chemistry of nitrogenous heterocyclic derivatives that is directed towards their\nanti-microbial profile; (3) To summarize the complete correlation of structural features of nitrogenous\nheterocyclic molecules with the pharmacological action including in silico as well as\nmechanistic studies to provide thoughts accompanying the generation of lead molecules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Antimicrobial potential of nitrogenous heterocyclic molecules has been displayed by\nrelating the structural features of various lead candidates with their in vitro as well as in vivo\nantimicrobial outcomes. In contrast, in silico computational analysis from different articles also\nhelped to predict the SAR of potent molecules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Nitrogen containing heterocycles are involved in a range of natural to synthetic analogues\nwith keen antimicrobial potency. It is an emerging need to generate new nitrogenous\nheterocyclic molecules in order to tackle the drug resistance in micro-organisms with more targeted\nselectivity as well as specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>To limit the side effects associated with them and to combat the microbes acquired\nresistance towards the current drug regimen, novel nitrogenous heterocycle based antimicrobial\nagents are essential to be developed. This review connects the structural units present\nin lead compounds with their promising antimicrobial action.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673301266240506083014","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:15:33Z","timestamp":1716768933000},"page":"9273-9323","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Recent Developments in the Antimicrobial Potential of Some Nitrogenous Heterocycles and their SAR Studies: A Review"],"prefix":"10.2174","volume":"32","author":[{"given":"Bhupender","family":"Nehra","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar-\n125001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar-\n125001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitra","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar-\n125001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viney","family":"Chawla","sequence":"additional","affiliation":[{"name":"University Institute of Pharmaceutical Sciences and Research, BFUHS, Faridkot,\n151203, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-9172","authenticated-orcid":true,"given":"Pooja A.","family":"Chawla","sequence":"additional","affiliation":[{"name":"University Institute of Pharmaceutical Sciences and Research, BFUHS, Faridkot,\n151203, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Grover","sequence":"additional","affiliation":[{"name":"KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad\n201206, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11648\/j.ajhc.20200601.12","volume":"6","author":"Yoda J.","year":"2020","unstructured":"Yoda J.; Overview of recent advances in 3-Hydroxycoumarin Chemistry as a bioactive heterocyclic compound. Amer J Heterocyclic Chem  2020,6,6","journal-title":"Amer J Heterocyclic Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkv147","volume":"70","author":"Huttner A.","year":"2015","unstructured":"Huttner A.; Verhaegh E.M.; Harbarth S.; Muller A.E.; Theuretzbacher U.; Mouton J.W.; Nitrofurantoin revisited: A systematic review and meta-analysis of controlled trials. J Antimicrob Chemother  2015,70(9),2456-2464","journal-title":"J Antimicrob Chemother"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"121067","DOI":"10.1016\/j.ijpharm.2021.121067","volume":"608","author":"Andrusenko I.","year":"2021","unstructured":"Andrusenko I.; Hamilton V.; Lanza A.E.; Hall C.L.; Mugnaioli E.; Potticary J.; Buanz A.; Gaisford S.; Piras A.M.; Zambito Y.; Hall S.R.; Gemmi M.; Structure determination, thermal stability and dissolution rate of \u03b4-indomethacin. Int J Pharm  2021,608,121067","journal-title":"Int J Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"103029","DOI":"10.1016\/j.bioorg.2019.103029","volume":"90","author":"Abdellatif K.R.A.","year":"2019","unstructured":"Abdellatif K.R.A.; Abdelall E.K.A.; Labib M.B.; Fadaly W.A.A.; Zidan T.H.; Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors. Bioorg Chem  2019,90,103029","journal-title":"Bioorg Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","volume":"55","author":"Colson P.","year":"2020","unstructured":"Colson P.; Rolain J.M.; Lagier J.C.; Brouqui P.; Raoult D.; Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents  2020,55(4),105932","journal-title":"Int J Antimicrob Agents"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.euroneuro.2019.10.012","volume":"29","author":"Kerckhove N.","year":"2019","unstructured":"Kerckhove N.; Boudieu L.; Ourties G.; Bourdier J.; Daulhac L.; Eschalier A.; Mallet C.; Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors. Eur Neuropsychopharmacol  2019,29(12),1419-1432","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13065-019-0566-y","volume":"13","author":"Abdelhamid A.O.","year":"2019","unstructured":"Abdelhamid A.O.; El Sayed I.E.; Zaki Y.H.; Hussein A.M.; Mangoud M.M.; Hosny M.A.; Utility of 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide in the synthesis of heterocyclic compounds with antimicrobial activity. BMC Chem  2019,13(1),48","journal-title":"BMC Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/jhet.704","volume":"49","author":"Bansode T.N.","year":"2012","unstructured":"Bansode T.N.; Meshram G.A.; Synthesis and antimicrobial activity of 4\u2010(10H\u2010Phenothiazin\u20102\u2010yl)\u2010pyrimidin\u20102(1H)\u2010one\/thione derivatives. J Heterocycl Chem  2012,49(5),1004-1008","journal-title":"J Heterocycl Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7868\/S0132342315040077","volume":"41","author":"El Azab I.H.","year":"2015","unstructured":"El Azab I.H.; Khaled K.M.; Synthesis and reactivity of enaminone of naphtho[b]1,4-oxazine: One pot synthesis of novel isolated and heterocycle-fused derivatives with antimicrobial and antifungal activities. Bioorg Khim  2015,41(4),475-490","journal-title":"Bioorg Khim"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1002\/jhet.2927","volume":"54","author":"Hassan M.M.","year":"2017","unstructured":"Hassan M.M.; Farouk O.; Synthesis and antimicrobial evaluation of some functionalized heterocycles derived from Novel Quinolinyl Chalcone. J Heterocycl Chem  2017,54(6),3133-3142","journal-title":"J Heterocycl Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3987\/COM-12-12520","volume":"85","author":"Riyadh S.M.","year":"2012","unstructured":"Riyadh S.M.; Kheder N.A.; Asiry A.M.; A facile and convenient synthesis of novel pyridine derivatives incorporating antipyrine moiety and investigation of their antimicrobial activities. Heterocycles  2012,85,2259","journal-title":"Heterocycles"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/jhet.3232","volume":"55","author":"Ramadan S.K.","year":"2018","unstructured":"Ramadan S.K.; Sallam H.A.; Synthesis, spectral characterization, cytotoxic, and antimicrobial activities of some novel heterocycles utilizing 1,3\u2010Diphenylpyrazole\u20104\u2010carboxalde-hyde thiosemicarbazone. J Heterocycl Chem  2018,55(8),1942-1954","journal-title":"J Heterocycl Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3987\/COM-21-14512","volume":"102","author":"Joshi H.S.","year":"2021","unstructured":"Joshi H.S.; Panchani N.M.; Facile A.; Efficient and catalyst free synthesis of imidazole, tetrazole and pyrimidine combined moiety as potential antimicrobial and antitubercular agents. Heterocycles  2021,102,1982","journal-title":"Heterocycles"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jgar.2021.10.019","volume":"29","author":"Keikha M.","year":"2022","unstructured":"Keikha M.; Askari P.; Ghazvini K.; Karbalaei M.; Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: A systematic review and meta-analysis. J Glob Antimicrob Resist  2022,29,420-429","journal-title":"J Glob Antimicrob Resist"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbmt.2012.08.012","volume":"19","author":"Srinivasan A.","year":"2013","unstructured":"Srinivasan A.; Wang C.; Srivastava D.K.; Burnette K.; Shenep J.L.; Leung W.; Hayden R.T.; Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  2013,19(1),94-101","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref=16","year":"2022","unstructured":"Global tuberculosis report 2020. WHO Available From:  https:\/\/www.who.int\/publications-detail-redirect\/97892400131312022"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1093\/cid\/ciab773","volume":"73","author":"Bhattarai S.","year":"2021","unstructured":"Bhattarai S.; Sharma B.K.; Subedi N.; Ranabhat S.; Baral M.P.; Burden of serious bacterial infections and multidrug-resistant organisms in an adult population of Nepal: A comparative analysis of minimally invasive tissue sampling informed mortality surveillance of community and hospital deaths. Clin Infect Dis  2021,73(Suppl. 5),S415-S421","journal-title":"Clin Infect Dis"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v6i9.29","volume":"6","author":"Edwin MD D.B.","year":"2018","unstructured":"Edwin MD D.B.; Antibacterial activity of Psidium guajava L. against certain multidrug resistant gram-negative and gram-positive bacteria. J Med Sci Clin Res  2018,6(9)","journal-title":"J Med Sci Clin Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"123888","DOI":"10.1016\/j.cej.2019.123888","volume":"385","author":"Kyzio\u0142 A.","year":"2020","unstructured":"Kyzio\u0142 A.; Khan W.; Sebastian V.; Kyzio\u0142 K.; Tackling microbial infections and increasing resistance involving formulations based on antimicrobial polymers. Chem Eng J  2020,385,123888","journal-title":"Chem Eng J"},{"key":"ref=20","year":"2024","unstructured":"Data and Statistics. CDC Available From:  https:\/\/www.cdc.gov\/tb\/statistics\/default.htm2024"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","volume":"69","author":"Sterling T.R.","year":"2020","unstructured":"Sterling T.R.; Njie G.; Zenner D.; Cohn D.L.; Reves R.; Ahmed A.; Menzies D.; Horsburgh C.R.; Crane C.M.; Burgos M.; LoBue P.; Winston C.A.; Belknap R.; Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep  2020,69(1),1-11","journal-title":"MMWR Recomm Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.annemergmed.2021.06.005","volume":"78","author":"Lai S.","year":"2021","unstructured":"Lai S.; Kitamura K.; Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020. Ann Emerg Med  2021,78(1),49-52","journal-title":"Ann Emerg Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jiph.2021.10.027","volume":"14","author":"Arumugam N.","year":"2021","unstructured":"Arumugam N.; Almansour A.I.; Suresh Kumar R.; Antimicrobial activities of spirooxindolopyrrolidine tethered dicarbonitrile heterocycles against multidrug resistant nosocomial pathogens. J Infect Public Health  2021,14(12),1810-1814","journal-title":"J Infect Public Health"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.procbio.2021.12.032","volume":"114","author":"Alaqeel S.I.","year":"2022","unstructured":"Alaqeel S.I.; Arumugam N.; Almansour A.I.; Suresh Kumar R.; Ponmurugan K.; Abdullah Al-Dhabi N.; Brindhadevi K.; Perumal K.; Synthesis and antimicrobial potential of spirooxindolopyrrolidine tethered oxindole heterocyclic hybrid against multidrug resistant microbial pathogens. Process Biochem  2022,114,66-70","journal-title":"Process Biochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2174\/0929867323666161213102127","volume":"24","author":"Kaczor A.A.","year":"2017","unstructured":"Kaczor A.A.; Polski A.; Sob\u00f3tka-Polska K.; Pachuta-Stec A.; Makarska-Bialokoz M.; Pitucha M.; Novel antibacterial compounds and their drug targets-successes and challenges. Curr Med Chem  2017,24(18),1948-1982","journal-title":"Curr Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"105039","DOI":"10.1016\/j.bioorg.2021.105039","volume":"113","author":"Wang J.","year":"2021","unstructured":"Wang J.; Zhang P.L.; Ansari M.F.; Li S.; Zhou C.H.; Molecular design and preparation of 2-aminothiazole sulfanilamide oximes as membrane active antibacterial agents for drug resistant Acinetobacter baumannii. Bioorg Chem  2021,113,105039","journal-title":"Bioorg Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.37897\/RJMP.2020.1.12","volume":"15","author":"Popescu F.D.","year":"2022","unstructured":"Popescu F.D.; Caraghiulea M.; Ganea C.S.; Preda M.; Stanescu A.M.A.; Nonirritating concentrations for skin testing in immediate antibiotic allergy. Romanian J Pharmaceut Prac  2022,15,60","journal-title":"Romanian J Pharmaceut Prac"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/B978-0-12-818882-8.00016-4","author":"Rehman K.","year":"2020","unstructured":"Rehman K.; Kamran S.H.; Akash M.S.H.;  Toxicity of antibioticsAntibiotics and Antimicrobial Resistance Genes in the Environment  2020,234-252","journal-title":"Toxicity of antibioticsAntibiotics and Antimicrobial Resistance Genes in the Environment"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.bioorg.2020.103908","volume":"100","author":"Reddy G.M.","year":"2020","unstructured":"Reddy G.M.; Kumari A.K.; Reddy V.H.; Garcia J.R.; Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided results. Bioorg Chem  2020,100,103908","journal-title":"Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.1021\/jacs.0c02329","volume":"142","author":"Du Y.","year":"2020","unstructured":"Du Y.; Qiu Y.; Meng X.; Feng J.; Tao J.; Liu W.; A heterotrimeric dehydrogenase complex functions with 2 distinct YcaO proteins to install 5 azole heterocycles into 35-membered sulfomycin thiopeptides. J Am Chem Soc  2020,142(18),8454-8463","journal-title":"J Am Chem Soc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/jac\/dkw236","volume":"71","author":"Soge O.O.","year":"2016","unstructured":"Soge O.O.; No D.; Michael K.E.; Dankoff J.; Lane J.; Vogel K.; Smedley J.; Roberts M.C.; Transmission of MDR MRSA between primates, their environment and personnel at a United States primate centre. J Antimicrob Chemother  2016,71(10),2798-2803","journal-title":"J Antimicrob Chemother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.chembiol.2016.11.007","volume":"23","author":"Reeve S.M.","year":"2016","unstructured":"Reeve S.M.; Scocchera E.W.; G-Dayanadan N.; Keshipeddy S.; Krucinska J.; Hajian B.; Ferreira J.; Nailor M.; Aeschlimann J.; Wright D.L.; Anderson A.C.; MRSA isolates from United States Hospitals carry dfrG and dfrK resistance genes and succumb to propargyl-linked antifolates. Cell Chem Biol  2016,23(12),1458-1467","journal-title":"Cell Chem Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tcmj.2016.03.002","volume":"28","author":"Hasan R.","year":"2016","unstructured":"Hasan R.; Acharjee M.; Noor R.; Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections. Tzu-Chi Med J  2016,28(2),49-53","journal-title":"Tzu-Chi Med J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1016\/j.bmcl.2017.10.042","volume":"27","author":"Choi P.J.","year":"2017","unstructured":"Choi P.J.; Sutherland H.S.; Tong A.S.T.; Blaser A.; Franzblau S.G.; Cooper C.B.; Lotlikar M.U.; Upton A.M.; Guillemont J.; Motte M.; Queguiner L.; Andries K.; Van den Broeck W.; Denny W.A.; Palmer B.D.; Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units. Bioorg Med Chem Lett  2017,27(23),5190-5196","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.jiph.2021.10.023","volume":"14","author":"Alaqeel S.I.","year":"2021","unstructured":"Alaqeel S.I.; Almansour A.I.; Arumugam N.; Kumar R.S.; Ponmurugan K.; Al-Dhabi N.A.; Antimicrobial activities of novel class of dispirooxindolopyrrolidine grafted indanedione hybrid heterocycles against carbapenemase producing Klebsiella pneumoniae (CKP). J Infect Public Health  2021,14(12),1870-1874","journal-title":"J Infect Public Health"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ejmech.2018.08.040","volume":"158","author":"Kalaria P.N.","year":"2018","unstructured":"Kalaria P.N.; Karad S.C.; Raval D.K.; A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery. Eur J Med Chem  2018,158,917-936","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ejmech.2006.12.038","volume":"42","author":"K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.","year":"2007","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; K\u00fc\u00e7\u00fckg\u00fczel \u0130.; Tatar E.; Rollas S.; \u015eahin F.; G\u00fcll\u00fcce M.; De Clercq E.; Kabasakal L.; Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur J Med Chem  2007,42(7),893-901","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jtice.2020.12.011","volume":"117","author":"Verma C.","year":"2020","unstructured":"Verma C.; Rhee K.Y.; Quraishi M.A.; Ebenso E.E.; Pyridine based N-heterocyclic compounds as aqueous phase corrosion inhibitors: A review. J Taiwan Inst Chem Eng  2020,117,265-277","journal-title":"J Taiwan Inst Chem Eng"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnmrs.2018.03.001","volume":"105","author":"Krivdin L.B.","year":"2018","unstructured":"Krivdin L.B.; Carbon-carbon spin-spin coupling constants: Practical applications of theoretical calculations. Prog Nucl Magn Reson Spectrosc  2018,105,54-99","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/acs.jmedchem.2c02115","volume":"66","author":"Tan L.","year":"2023","unstructured":"Tan L.; Wu C.; Zhang J.; Yu Q.; Wang X.; Zhang L.; Ge M.; Wang Z.; Ouyang L.; Wang Y.; Design, synthesis, and biological evaluation of heterocyclic-fused pyrimidine chemotypes guided by x-ray crystal structure with potential antitumor and anti-multidrug resistance efficacy targeting the colchicine binding site. J Med Chem  2023,66(5),3588-3620","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-323-99988-5.00010-3","author":"Nehra B.","year":"2023","unstructured":"Nehra B.; Chawla P.A.; Prasher P.; Bhagat D.S.;  Heterocycles in managing inflammatory diseasesRecent Developments in Anti-Inflammatory Therapy  2023,295-313","journal-title":"Heterocycles in managing inflammatory diseasesRecent Developments in Anti-Inflammatory Therapy"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/329412","volume":"2013","author":"Verma A.","year":"2013","unstructured":"Verma A.; Joshi S.; Singh D.; Imidazole: Having versatile biological activities. J Chem  2013,2013,1-12","journal-title":"J Chem"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.2174\/1570163816666190320123340","volume":"16","author":"Chopra P.","year":"2019","unstructured":"Chopra P.; Sahu J.; Biological significance of imidazole-based analogues in new drug development. Curr Drug Discov Technol  2019,16","journal-title":"Curr Drug Discov Technol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/13543776.2012.667403","volume":"22","author":"Shaaban M.R.","year":"2012","unstructured":"Shaaban M.R.; Mayhoub A.S.; Farag A.M.; Recent advances in the therapeutic applications of pyrazolines. Expert Opin Ther Pat  2012,22(3),253-291","journal-title":"Expert Opin Ther Pat"},{"key":"ref=45","first-page":"727","volume":"4","author":"Ganesh A.","year":"2013","unstructured":"Ganesh A.; Biological activities of some pyrazoline derivatives. Int J Pharma Bio Sci  2013,4,727-733","journal-title":"Int J Pharma Bio Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejmech.2006.08.004","volume":"42","author":"Ali M.A.","year":"2007","unstructured":"Ali M.A.; Shaharyar M.; Siddiqui A.A.; Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem  2007,42(2),268-275","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejmech.2015.10.047","volume":"107","author":"Joshi S.D.","year":"2016","unstructured":"Joshi S.D.; Dixit S.R.; Kirankumar M.N.; Aminabhavi T.M.; Raju K.V.S.N.; Narayan R.; Lherbet C.; Yang K.S.; Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. Eur J Med Chem  2016,107,133-152","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"104099","DOI":"10.1016\/j.bioorg.2020.104099","volume":"102","author":"Patel H.","year":"2020","unstructured":"Patel H.; Chaudhari K.; Jain P.; Surana S.; Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis. Bioorg Chem  2020,102,104099","journal-title":"Bioorg Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ejmech.2018.06.033","volume":"155","author":"Chiarelli L.R.","year":"2018","unstructured":"Chiarelli L.R.; Mori M.; Barlocco D.; Beretta G.; Gelain A.; Pini E.; Porcino M.; Mori G.; Stelitano G.; Costantino L.; Lapillo M.; Bonanni D.; Poli G.; Tuccinardi T.; Villa S.; Meneghetti F.; Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents. Eur J Med Chem  2018,155,754-763","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/asia.201801805","volume":"14","author":"Santoso K.T.","year":"2019","unstructured":"Santoso K.T.; Cheung C.Y.; Hards K.; Cook G.M.; Stocker B.L.; Timmer M.S.M.; Synthesis and investigation of phthalazinones as antitubercular agents. Chem Asian J  2019,14(8),1278-1285","journal-title":"Chem Asian J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejmech.2006.10.001","volume":"42","author":"\u00d6zdemir A.","year":"2007","unstructured":"\u00d6zdemir A.; Turan-Zitouni G.; As\u0131m Kaplanc\u0131kl\u0131 Z.; Revial G.; G\u00fcven K.; Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives. Eur J Med Chem  2007,42(3),403-409","journal-title":"Eur J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejmech.2006.07.011","volume":"42","author":"Karthikeyan M.S.","year":"2007","unstructured":"Karthikeyan M.S.; Holla B.S.; Kumari N.S.; Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines. Eur J Med Chem  2007,42(1),30-36","journal-title":"Eur J Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/molecules21020087","volume":"21","author":"Kalinowska-Lis U.","year":"2016","unstructured":"Kalinowska-Lis U.; Felczak A.; Ch\u0119ci\u0144ska L.; Szab\u0142owska-Gadomska I.; Patyna E.; Ma\u0142ecki M.; Lisowska K.; Ochocki J.; Antibacterial activity and cytotoxicity of Silver(I) complexes of pyridine and (Benz)Imidazole Derivatives. X-ray crystal structure of [Ag(2,6-di(CH2OH)py)2] NO3. Molecules  2016,21(2),87","journal-title":"Molecules"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1021\/acsomega.9b01109","volume":"4","author":"Singh A.","year":"2019","unstructured":"Singh A.; Singh J.V.; Rana A.; Bhagat K.; Gulati H.K.; Kumar R.; Salwan R.; Bhagat K.; Kaur G.; Singh N.; Kumar R.; Singh H.; Sharma S.; Bedi P.M.S.; Monocarbonyl curcumin-based molecular hybrids as potent antibacterial agents. ACS Omega  2019,4(7),11673-11684","journal-title":"ACS Omega"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1021\/acs.jmedchem.7b01704","volume":"61","author":"Niu Y.","year":"2018","unstructured":"Niu Y.; Wang M.; Cao Y.; Nimmagadda A.; Hu J.; Wu Y.; Cai J.; Ye X.S.; Rational design of Dimeric Lysine N -Alkylamides as potent and broad-spectrum antibacterial agents. J Med Chem  2018,61(7),2865-2874","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"107979","DOI":"10.1016\/j.exppara.2020.107979","volume":"218","author":"Kanwal M.","year":"2020","unstructured":"Kanwal M.; Mungroo M.R.; Anwar A.; Ali F.; Khan S.; Abdullah M.A.; Siddiqui R.; Khan K.M.; Khan N.A.; Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae. Exp Parasitol  2020,218,107979","journal-title":"Exp Parasitol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1007\/s10853-020-04793-2","volume":"55","author":"Kusrini E.","year":"2020","unstructured":"Kusrini E.; Hashim F.; Saleh M.I.; Adnan R.; Usman A.; Zakaria I.N.; Prihandini W.W.; Putra N.; Prasetyanto E.A.; Monoclinic cerium(III) picrate tetraethylene glycol complex: Design, synthesis and biological evaluation as anti-amoebic activity against Acanthamoeba sp. J Mater Sci  2020,55(23),9795-9811","journal-title":"J Mater Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejmech.2007.10.032","volume":"44","author":"Abid M.","year":"2009","unstructured":"Abid M.; Bhat A.R.; Athar F.; Azam A.; Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines. Eur J Med Chem  2009,44(1),417-425","journal-title":"Eur J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ejmech.2007.11.005","volume":"44","author":"Bhat A.R.","year":"2009","unstructured":"Bhat A.R.; Athar F.; Azam A.; Bis-pyrazolines: Synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica. Eur J Med Chem  2009,44(1),426-431","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ejmech.2018.03.033","volume":"150","author":"Negi B.","year":"2018","unstructured":"Negi B.; Poonan P.; Ansari M.F.; Kumar D.; Aggarwal S.; Singh R.; Azam A.; Rawat D.S.; Synthesis, antiamoebic activity and docking studies of metronidazole-triazole-styryl hybrids. Eur J Med Chem  2018,150,633-641","journal-title":"Eur J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ejmech.2009.10.023","volume":"45","author":"Acharya B.N.","year":"2010","unstructured":"Acharya B.N.; Saraswat D.; Tiwari M.; Shrivastava A.K.; Ghorpade R.; Bapna S.; Kaushik M.P.; Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur J Med Chem  2010,45(2),430-438","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1016\/j.bmcl.2010.05.069","volume":"20","author":"Wanare G.","year":"2010","unstructured":"Wanare G.; Aher R.; Kawathekar N.; Ranjan R.; Kaushik N.K.; Sahal D.; Synthesis of novel \u03b1-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors. Bioorg Med Chem Lett  2010,20(15),4675-4678","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ejmech.2017.11.083","volume":"143","author":"Pavi\u0107 K.","year":"2018","unstructured":"Pavi\u0107 K.; Perkovi\u0107 I.; Posp\u00ed\u0161ilov\u00e1 \u0160.; Machado M.; Fontinha D.; Prud\u00eancio M.; Jampilek J.; Coffey A.; Endersen L.; Rimac H.; Zorc B.; Primaquine hybrids as promising antimycobacterial and antimalarial agents. Eur J Med Chem  2018,143,769-779","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bmcl.2018.02.051","volume":"28","author":"Johnson-Ajinwo O.R.","year":"2018","unstructured":"Johnson-Ajinwo O.R.; Ullah I.; Mbye H.; Richardson A.; Horrocks P.; Li W.W.; The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents. Bioorg Med Chem Lett  2018,28(7),1219-1222","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1016\/j.bmc.2018.05.041","volume":"26","author":"\u00c7apc\u0131 Karag\u00f6z A.","year":"2018","unstructured":"\u00c7apc\u0131 Karag\u00f6z A.; Reiter C.; Seo E.J.; Gruber L.; Hahn F.; Leidenberger M.; Klein V.; Hampel F.; Friedrich O.; Marschall M.; Kappes B.; Efferth T.; Tsogoeva S.B.; Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin. Bioorg Med Chem  2018,26(12),3610-3618","journal-title":"Bioorg Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/14756360903373368","volume":"25","author":"\u00d6zdemir A.","year":"2010","unstructured":"\u00d6zdemir A.; Turan-Zitouni G.; As\u0131m Kaplanc\u0131kl\u0131 Z.; Revial G.; Demirci F.; \u0130\u015fcan G.; Preparation of some pyrazoline derivatives and evaluation of their antifungal activities. J Enzyme Inhib Med Chem  2010,25(4),565-571","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3390\/molecules18032683","volume":"18","author":"Hassan S.","year":"2013","unstructured":"Hassan S.; Synthesis, antibacterial and antifungal activity of some new pyrazoline and pyrazole derivatives. Molecules  2013,18(3),2683-2711","journal-title":"Molecules"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1021\/acs.jafc.9b05942","volume":"67","author":"Wu Y.Y.","year":"2019","unstructured":"Wu Y.Y.; Shao W.B.; Zhu J.J.; Long Z.Q.; Liu L.W.; Wang P.Y.; Li Z.; Yang S.; Novel 1,3,4-oxadiazole-2-carbohydrazides as prospective agricultural antifungal agents potentially targeting succinate dehydrogenase. J Agric Food Chem  2019,67(50),13892-13903","journal-title":"J Agric Food Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/cmdc.201800331","volume":"13","author":"Obando D.","year":"2018","unstructured":"Obando D.; Koda Y.; Pantarat N.; Lev S.; Zuo X.; Bijosono Oei J.; Widmer F.; Djordjevic J.T.; Sorrell T.C.; Jolliffe K.A.; Synthesis and evaluation of a series of bis(pentylpyridinium) compounds as antifungal agents. ChemMedChem  2018,13(14),1421-1436","journal-title":"ChemMedChem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ejmech.2017.10.046","volume":"143","author":"El Shehry M.F.","year":"2018","unstructured":"El Shehry M.F.; Ghorab M.M.; Abbas S.Y.; Fayed E.A.; Shedid S.A.; Ammar Y.A.; Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents. Eur J Med Chem  2018,143,1463-1473","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"23045","DOI":"10.1039\/C9RA05139B","volume":"9","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Li P.; Su S.; Chen M.; He J.; Liu L.; He M.; Wang H.; Xue W.; Synthesis and antibacterial and antiviral activities of myricetin derivatives containing a 1,2,4-triazole Schiff base. RSC Advances  2019,9(40),23045-23052","journal-title":"RSC Advances"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.bmcl.2018.09.019","volume":"28","author":"Karypidou K.","year":"2018","unstructured":"Karypidou K.; Ribone S.R.; Quevedo M.A.; Persoons L.; Pannecouque C.; Helsen C.; Claessens F.; Dehaen W.; Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents. Bioorg Med Chem Lett  2018,28(21),3472-3476","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1002\/slct.201900814","volume":"4","author":"Goma\u2019a H.A.M.","year":"2019","unstructured":"Goma\u2019a H.A.M.; Ghaly M.A.; Abou-zeid L.A.; Badria F.A.; Shehata I.A.; El-Kerdawy M.M.; Synthesis, biological evaluation and in silico studies of 1,2,4\u2010triazole and 1,3,4\u2010thiadiazole derivatives as antiherpetic agents. ChemistrySelect  2019,4(21),6421-6428","journal-title":"ChemistrySelect"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"103446","DOI":"10.1016\/j.bioorg.2019.103446","volume":"94","author":"Aouad M.R.","year":"2020","unstructured":"Aouad M.R.; Al-Mohammadi H.M.; Al-blewi F.F.; Ihmaid S.; Elbadawy H.M.; Althagfan S.S.; Rezki N.; Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors. Bioorg Chem  2020,94,103446","journal-title":"Bioorg Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2018.02.012","volume":"152","author":"Edwards T.G.","year":"2018","unstructured":"Edwards T.G.; Fisher C.; Antiviral activity of pyrrole-imidazole polyamides against SV40 and BK polyomaviruses. Antiviral Res  2018,152,68-75","journal-title":"Antiviral Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/1381612826666200206093815","volume":"26","author":"Fesatidou M.","year":"2020","unstructured":"Fesatidou M.; Petrou A.; Athina G.; Heterocycle compounds with antimicrobial activity, current pharmaceutical design. Curr Pharm Des  2020,26(8),867-904","journal-title":"Curr Pharm Des"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2174\/1389557516666160609075620","volume":"16","author":"Desai N.","year":"2016","unstructured":"Desai N.; Trivedi A.; Pandit U.; Dodiya A.; Kameswara Rao V.; Desai P.; Hybrid bioactive heterocycles as potential antimicrobial agents: A review. Mini Rev Med Chem  2016,16(18),1500-1526","journal-title":"Mini Rev Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22159\/ajpcr.2017.v10i2.15673","volume":"10","author":"Sharma P.K.","year":"2017","unstructured":"Sharma P.K.; A review: Antimicrobial agents based on nitrogen and sulfur containing heterocycles. Asian J Pharm Clin Res  2017,10(2),47","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"15213","DOI":"10.1039\/D1RA00341K","volume":"11","author":"Jalageri M.D.","year":"2021","unstructured":"Jalageri M.D.; Nagaraja A.; Puttaiahgowda Y.M.; Piperazine based antimicrobial polymers: A review. RSC Advances  2021,11(25),15213-15230","journal-title":"RSC Advances"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-023-10612-y","author":"Desai N.C.","year":"2023","unstructured":"Desai N.C.; Jadeja D.J.; Jethawa A.M.; Ahmad I.; Patel H.; Dave B.P.; Design and synthesis of some novel hybrid molecules based on 4-thiazolidinone bearing pyridine-pyrazole scaffolds: Molecular docking and molecular dynamics simulations of its major constituent onto DNA gyrase inhibition. Mol Divers  2023,1-17","journal-title":"Mol Divers"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/nano12071215","volume":"12","author":"Alfei S.","year":"2022","unstructured":"Alfei S.; Zuccari G.; Caviglia D.; Brullo C.; Synthesis and characterization of pyrazole-enriched cationic nanoparticles as new promising antibacterial agent by mutual cooperation. Nanomaterials (Basel)  2022,12(7),1215","journal-title":"Nanomaterials (Basel)"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1007\/s13738-022-02575-y","volume":"19","author":"Saadon K.E.","year":"2022","unstructured":"Saadon K.E.; Taha N.M.H.; Mahmoud N.A.; Elhagali G.A.M.; Ragab A.; Synthesis, characterization, and in vitro antibacterial activity of some new pyridinone and pyrazole derivatives with some in silico ADME and molecular modeling study. J Indian Chem Soc  2022,19(9),3899-3917","journal-title":"J Indian Chem Soc"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00044-017-1855-4","volume":"26","author":"Ansari M.I.","year":"2017","unstructured":"Ansari M.I.; Khan S.A.; Synthesis and antimicrobial activity of some novel quinoline-pyrazoline-based coumarinyl thiazole derivatives. Med Chem Res  2017,26(7),1481-1496","journal-title":"Med Chem Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.bmcl.2015.05.033","volume":"25","author":"Shahavar Sulthana S.","year":"2015","unstructured":"Shahavar Sulthana S.; Arul Antony S.; Balachandran C.; Syed Shafi S.; Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies. Bioorg Med Chem Lett  2015,25(14),2753-2757","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejmech.2014.12.055","volume":"92","author":"Alt\u0131ntop M.D.","year":"2015","unstructured":"Alt\u0131ntop M.D.; \u00d6zdemir A.; Turan-Zitouni G.; Ilg\u0131n S.; Atl\u0131 \u00d6.; Demirel R.; Kaplanc\u0131kl\u0131 Z.A.; A novel series of thiazolyl\u2013pyrazoline derivatives: Synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity. Eur J Med Chem  2015,92,342-352","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s11164-016-2774-6","volume":"43","author":"Archana S.","year":"2017","unstructured":"Archana S.; Ranganathan R.; Dinesh M.; Arul P.; Ponnuswamy A.; Kalaiselvi P.; Chellammal S.; Subramanian G.; Design, synthesis, and antibacterial studies of potent pyrazolinyltriazoles. Res Chem Intermed  2017,43(4),2471-2490","journal-title":"Res Chem Intermed"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00044-016-1732-6","volume":"26","author":"Desai N.C.","year":"2017","unstructured":"Desai N.C.; Patel B.Y.; Dave B.P.; Synthesis and antimicrobial activity of novel quinoline derivatives bearing pyrazoline and pyridine analogues. Med Chem Res  2017,26(1),109-119","journal-title":"Med Chem Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bmc.2017.02.025","volume":"25","author":"Mishra V.K.","year":"2017","unstructured":"Mishra V.K.; Mishra M.; Kashaw V.; Kashaw S.K.; Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents. Bioorg Med Chem  2017,25(6),1949-1962","journal-title":"Bioorg Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1007\/s00044-015-1385-x","volume":"24","author":"Nikam M.D.","year":"2015","unstructured":"Nikam M.D.; Mahajan P.S.; Damale M.G.; Sangshetti J.N.; Dabhade S.K.; Shinde D.W.; Gill C.H.; Synthesis, molecular docking and biological evaluation of some novel tetrazolo[1,5-a]quinoline incorporated pyrazoline and isoxazoline derivatives. Med Chem Res  2015,24(9),3372-3386","journal-title":"Med Chem Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejmech.2015.03.031","volume":"95","author":"Bano S.","year":"2015","unstructured":"Bano S.; Alam M.S.; Javed K.; Dudeja M.; Das A.K.; Dhulap A.; Synthesis, biological evaluation and molecular docking of some substituted pyrazolines and isoxazolines as potential antimicrobial agents. Eur J Med Chem  2015,95,96-103","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1039\/c3ob41953c","volume":"12","author":"Liu J.J.","year":"2014","unstructured":"Liu J.J.; Sun J.; Fang Y.B.; Yang Y.A.; Jiao R.H.; Zhu H.L.; Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. Org Biomol Chem  2014,12(6),998-1008","journal-title":"Org Biomol Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.biopha.2018.04.061","volume":"103","author":"Abrigach F.","year":"2018","unstructured":"Abrigach F.; Rokni Y.; Takfaoui A.; Khoutoul M.; Doucet H.; Asehraou A.; Touzani R.; In vitro screening, homology modeling and molecular docking studies of some pyrazole and imidazole derivatives. Biomed Pharmacother  2018,103,653-661","journal-title":"Biomed Pharmacother"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13065-019-0623-6","volume":"13","author":"Bouchal B.","year":"2019","unstructured":"Bouchal B.; Abrigach F.; Takfaoui A.; Elidrissi Errahhali M.; Elidrissi Errahhali M.; Dixneuf P.H.; Doucet H.; Touzani R.; Bellaoui M.; Identification of novel antifungal agents: Antimicrobial evaluation, SAR, ADME\u2013Tox and molecular docking studies of a series of imidazole derivatives. BMC Chem  2019,13(1),100","journal-title":"BMC Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ejmech.2017.11.100","volume":"143","author":"Hu Y.","year":"2018","unstructured":"Hu Y.; Shen Y.; Wu X.; Tu X.; Wang G.X.; Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents. Eur J Med Chem  2018,143,958-969","journal-title":"Eur J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/molecules23051212","volume":"23","author":"Sko\u010dibu\u0161i\u0107 M.","year":"2018","unstructured":"Sko\u010dibu\u0161i\u0107 M.; Od\u017eak R.; Rami\u0107 A.; Smoli\u0107 T.; Hrenar T.; Primo\u017ei\u010d I.; Novel imidazole aldoximes with broad-spectrum antimicrobial potency against multidrug resistant gram-negative bacteria. Molecules  2018,23(5),1212","journal-title":"Molecules"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.kijoms.2018.01.006","volume":"4","author":"Brahmbhatt H.","year":"2018","unstructured":"Brahmbhatt H.; Molnar M.; Pavi\u0107 V.; Pyrazole nucleus fused tri-substituted imidazole derivatives as antioxidant and antibacterial agents. Karbala Int J Modern Sci  2018,4(2),200-206","journal-title":"Karbala Int J Modern Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"103277","DOI":"10.1016\/j.bioorg.2019.103277","volume":"92","author":"Khalili Arjomandi O.","year":"2019","unstructured":"Khalili Arjomandi O.; Kavoosi M.; Adibi H.; Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-\u03b2-lactamase IMP-1. Bioorg Chem  2019,92,103277","journal-title":"Bioorg Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molstruc.2019.07.071","volume":"1197","author":"Slassi S.","year":"2019","unstructured":"Slassi S.; Aarjane M.; Yamni K.; Amine A.; Synthesis, crystal structure, DFT calculations, Hirshfeld surfaces, and antibacterial activities of schiff base based on imidazole. J Mol Struct  2019,1197,547-554","journal-title":"J Mol Struct"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12154-016-0162-8","volume":"10","author":"Sharma S.","year":"2017","unstructured":"Sharma S.; Sharma V.; Singh G.; Kaur H.; Srivastava S.; Ishar M.P.S.; 2-(chromon-3-yl)imidazole derivatives as potential antimicrobial agents: Synthesis, biological evaluation and molecular docking studies. J Chem Biol  2017,10(1),35-44","journal-title":"J Chem Biol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.14233\/ajchem.2017.20738","volume":"29","author":"Ramamurthy S.","year":"2017","unstructured":"Ramamurthy S.; Jayachandran E.; Synthesis and antimicrobial evaluation of some new thiazolo imidazole analogs. Asian J Chem  2017,29(12),2639-2642","journal-title":"Asian J Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/14756366.2017.1327522","volume":"32","author":"De Vita D.","year":"2017","unstructured":"De Vita D.; Angeli A.; Pandolfi F.; Bortolami M.; Costi R.; Di Santo R.; Suffredini E.; Ceruso M.; Del Prete S.; Capasso C.; Scipione L.; Supuran C.T.; Inhibition of the \u03b1-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties. J Enzyme Inhib Med Chem  2017,32(1),798-804","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.bmcl.2016.04.070","volume":"26","author":"Wen S.Q.","year":"2016","unstructured":"Wen S.Q.; Jeyakkumar P.; Avula S.R.; Zhang L.; Zhou C.H.; Discovery of novel berberine imidazoles as safe antimicrobial agents by down regulating ROS generation. Bioorg Med Chem Lett  2016,26(12),2768-2773","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.molstruc.2016.08.021","volume":"1127","author":"Rajaraman D.","year":"2017","unstructured":"Rajaraman D.; Sundararajan G.; Loganath N.K.; Krishnasamy K.; Synthesis, molecular structure, DFT studies and antimicrobial activities of some novel 3-(1-(3,4-dimethoxyphenethyl)-4,5-diphenyl-1H-imidazol-2-yl)-1H-indole derivatives and its molecular docking studies. J Mol Struct  2017,1127,597-610","journal-title":"J Mol Struct"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"115007","DOI":"10.1016\/j.ejmech.2022.115007","volume":"246","author":"Ni T.","year":"2023","unstructured":"Ni T.; Chi X.; Xie F.; Li L.; Wu H.; Hao Y.; Wang X.; Zhang D.; Jiang Y.; Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents. Eur J Med Chem  2023,246,115007","journal-title":"Eur J Med Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"133966","DOI":"10.1016\/j.molstruc.2022.133966","volume":"1271","author":"Merzouki O.","year":"2023","unstructured":"Merzouki O.; Arrousse N.; El Barnossi A.; Ech-chihbi E.; Fernine Y.; Iraqi Housseini A.; Rais Z.; Taleb M.; Eco-friendly synthesis, characterization, in silico ADMET and molecular docking analysis of novel carbazole derivatives as antibacterial and antifungal agents. J Mol Struct  2023,1271,133966","journal-title":"J Mol Struct"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/molecules23112970","volume":"23","author":"Edrees M.","year":"2018","unstructured":"Edrees M.; Melha S.; Saad A.; Kheder N.; Gomha S.; Muhammad Z.; Eco-friendly synthesis, characterization and biological evaluation of some novel pyrazolines containing thiazole moiety as potential anticancer and antimicrobial agents. Molecules  2018,23(11),2970","journal-title":"Molecules"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/molecules21080969","volume":"21","author":"Montoya A.","year":"2016","unstructured":"Montoya A.; Quiroga J.; Abonia R.; Derita M.; Sortino M.; Ornelas A.; Zacchino S.; Insuasty B.; Hybrid molecules containing a 7-Chloro-4-Aminoquinoline nucleus and a substituted 2-Pyrazoline with antiproliferative and antifungal activity. Molecules  2016,21(8),969","journal-title":"Molecules"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.bmc.2016.11.051","volume":"25","author":"Zhao D.","year":"2017","unstructured":"Zhao D.; Zhao S.; Zhao L.; Zhang X.; Wei P.; Liu C.; Hao C.; Sun B.; Su X.; Cheng M.; Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies. Bioorg Med Chem  2017,25(2),750-758","journal-title":"Bioorg Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.bmcl.2019.07.037","volume":"29","author":"Zhao S.","year":"2019","unstructured":"Zhao S.; Zhao L.; Zhang X.; Wei P.; Wu M.; Su X.; Sun B.; Zhao D.; Cheng M.; Design, synthesis and evaluation of biphenyl imidazole analogues as potent antifungal agents. Bioorg Med Chem Lett  2019,29(17),2448-2451","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s11094-018-1741-5","volume":"51","author":"Olender D.","year":"2018","unstructured":"Olender D.; Zaprutko L.; Mertas A.; Szliszka E.; Wyrozumski D.; Kr\u00f3l W.; Anti-candida activity of 4-morpholino-5-nitro- and 4,5-dinitro-imidazole derivatives. Pharm Chem J  2018,51(12),1063-1067","journal-title":"Pharm Chem J"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/molecules23040831","volume":"23","author":"Osmaniye D.","year":"2018","unstructured":"Osmaniye D.; Kaya Cavusoglu B.; Saglik B.; Levent S.; Acar Cevik U.; Atli O.; Synthesis and anticandidal activity of new imidazole-chalcones. Molecules  2018,23(4),831","journal-title":"Molecules"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.bmcl.2019.07.022","volume":"29","author":"Bolous M.","year":"2019","unstructured":"Bolous M.; Arumugam N.; Almansour A.I.; Suresh Kumar R.; Maruoka K.; Antharam V.C.; Thangamani S.; Broad-spectrum antifungal activity of spirooxindolo-pyrrolidine tethered indole\/imidazole hybrid heterocycles against fungal pathogens. Bioorg Med Chem Lett  2019,29(16),2059-2063","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jhet.3388","volume":"56","author":"I\u015f\u0131k A.","year":"2019","unstructured":"I\u015f\u0131k A.; Acar \u00c7evik U.; Sa\u011fl\u0131k B.N.; \u00d6zkay Y.; Synthesis, Characterization, and molecular docking study of some novel imidazole derivatives as potential antifungal agents. J Heterocycl Chem  2019,56(1),142-152","journal-title":"J Heterocycl Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00044-019-02369-7","volume":"28","author":"Shojaei P.","year":"2019","unstructured":"Shojaei P.; Mokhtari B.; Ghorbanpoor M.; Synthesis, in vitro antifungal evaluation and docking studies of novel derivatives of imidazoles and benzimidazoles. Med Chem Res  2019,28(9),1359-1367","journal-title":"Med Chem Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.bmc.2018.02.051","volume":"26","author":"Jeanmart S.","year":"2018","unstructured":"Jeanmart S.; Gagnepain J.; Maity P.; Lamberth C.; Cederbaum F.; Rajan R.; Jacob O.; Blum M.; Bieri S.; Synthesis and fungicidal activity of novel imidazole-based ketene dithioacetals. Bioorg Med Chem  2018,26(8),2009-2016","journal-title":"Bioorg Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1016\/j.bmc.2015.06.053","volume":"23","author":"Wani M.Y.","year":"2015","unstructured":"Wani M.Y.; Ahmad A.; Shiekh R.A.; Al-Ghamdi K.J.; Sobral A.J.F.N.; Imidazole clubbed 1,3,4-oxadiazole derivatives as potential antifungal agents. Bioorg Med Chem  2015,23(15),4172-4180","journal-title":"Bioorg Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/molecules28041712","volume":"28","author":"Lusardi M.","year":"2023","unstructured":"Lusardi M.; Basilico N.; Rotolo C.; Parapini S.; Spallarossa A.; Antimalarial activity of tri- and tetra-substituted Anilino pyrazoles. Molecules  2023,28(4),1712","journal-title":"Molecules"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"110379","DOI":"10.1016\/j.cbi.2023.110379","volume":"373","author":"Kumar A.","year":"2023","unstructured":"Kumar A.; Jain S.; Chauhan S.; Aggarwal S.; Saini D.; Novel hybrids of quinoline with pyrazolylchalcones as potential antimalarial agents: Synthesis, biological evaluation, molecular docking and ADME prediction. Chem Biol Interact  2023,373,110379","journal-title":"Chem Biol Interact"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.bmcl.2018.03.058","volume":"28","author":"Himangini D.","year":"2018","unstructured":"Himangini D.; Pathak D.P.; Sharma V.; Kumar S.; Designing novel inhibitors against falcipain-2 of Plasmodium falciparum. Bioorg Med Chem Lett  2018,28(9),1566-1569","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","volume":"149","author":"Kumar G.","year":"2018","unstructured":"Kumar G.; Tanwar O.; Kumar J.; Akhter M.; Sharma S.; Pillai C.R.; Alam M.M.; Zama M.S.; Pyrazole-pyrazoline as promising novel antimalarial agents: A mechanistic study. Eur J Med Chem  2018,149,139-147","journal-title":"Eur J Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejmech.2016.07.055","volume":"123","author":"Pandey A.K.","year":"2016","unstructured":"Pandey A.K.; Sharma S.; Pandey M.; Alam M.M.; Shaquiquzzaman M.; Akhter M.; 4, 5-Dihydrooxazole-pyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents. Eur J Med Chem  2016,123,476-486","journal-title":"Eur J Med Chem"},{"key":"ref=122","first-page":"121","volume":"38","author":"Tuha A.","year":"2014","unstructured":"Tuha A.; Bekhit A.A.; Seid Y.; Synthesis and biological screening of some thienyl and phenyl pyrazoline derivatives as antimalarial agent. Thaiphesatchasan  2014,38,121-129","journal-title":"Thaiphesatchasan"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00044-014-1188-5","volume":"24","author":"Marella A.","year":"2015","unstructured":"Marella A.; Akhter M.; Shaquiquzzaman M.; Tanwar O.; Verma G.; Alam M.M.; Synthesis, 3D-QSAR and docking studies of pyrimidine nitrile-pyrazoline: A novel class of hybrid antimalarial agents. Med Chem Res  2015,24(3),1018-1037","journal-title":"Med Chem Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"102933","DOI":"10.1016\/j.bioorg.2019.102933","volume":"88","author":"Raghuvanshi D.S.","year":"2019","unstructured":"Raghuvanshi D.S.; Verma N.; Singh S.V.; Khare S.; Pal A.; Negi A.S.; Synthesis of thymol-based pyrazolines: An effort to perceive novel potent-antimalarials. Bioorg Chem  2019,88,102933","journal-title":"Bioorg Chem"},{"key":"ref=125","first-page":"318","volume":"9","author":"Akhter W.","year":"2015","unstructured":"Akhter W.; Marella A.; Shaquiquzzaman M.; Akhter M.; Alam M.M.; Microwave assissted synthesis of pyrazoline-coumarin hybrids and their in vitro antimalarial evaluation. J Pharm Res  2015,9,318-322","journal-title":"J Pharm Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21088\/jpmc.2395.6615.3117.1","volume":"3","author":"Akhtar W.","year":"2017","unstructured":"Akhtar W.; Khan M.F.; Verma G.; Shaquiquzzaman M.; Akhter M.; Marella A.; Parmar S.; Khatoon R.; Alam M.M.; Coumarin-pyrazoline derivatives: Their one-pot microwave assisted synthesis and anti-malarial activity. J Pharmaceut Med Chem  2017,3,6-9","journal-title":"J Pharmaceut Med Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bioorg.2018.06.012","volume":"80","author":"Kondaparla S.","year":"2018","unstructured":"Kondaparla S.; Manhas A.; Dola V.R.; Srivastava K.; Puri S.K.; Katti S.B.; Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline. Bioorg Chem  2018,80,204-211","journal-title":"Bioorg Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"114959","DOI":"10.1016\/j.ejmech.2022.114959","volume":"246","author":"Sabt A.","year":"2023","unstructured":"Sabt A.; Eldehna W.M.; Ibrahim T.M.; Bekhit A.A.; Batran R.Z.; New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: Design, synthesis, and molecular modeling studies. Eur J Med Chem  2023,246,114959","journal-title":"Eur J Med Chem"},{"key":"ref=129","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2598794\/v1","author":"Berhe H.G.","year":"2024","unstructured":"Berhe H.G.; Birhan Y.S.; Beshay B.Y.; Habib H.J.; Hymete A.; Bekhit A.A.; Synthesis, antileishmanial, antimalarial evaluation and Molecular Docking Study of some hydrazine-coupled pyrazole derivatives. Preprint  2024","journal-title":"Preprint"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1016\/j.ejmech.2010.07.028","volume":"45","author":"Hayat F.","year":"2010","unstructured":"Hayat F.; Salahuddin A.; Umar S.; Azam A.; Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail. Eur J Med Chem  2010,45(10),4669-4675","journal-title":"Eur J Med Chem"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ejmech.2012.03.049","volume":"54","author":"Wani M.Y.","year":"2012","unstructured":"Wani M.Y.; Bhat A.R.; Azam A.; Lee D.H.; Choi I.; Athar F.; Synthesis and in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted pyrazoline derivatives as Entamoeba histolytica growth inhibitors. Eur J Med Chem  2012,54,845-854","journal-title":"Eur J Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejmech.2018.06.063","volume":"156","author":"Saccoliti F.","year":"2018","unstructured":"Saccoliti F.; Madia V.N.; Tudino V.; De Leo A.; Pescatori L.; Messore A.; De Vita D.; Scipione L.; Brun R.; Kaiser M.; M\u00e4ser P.; Calvet C.M.; Jennings G.K.; Podust L.M.; Costi R.; Di Santo R.; Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents. Eur J Med Chem  2018,156,53-60","journal-title":"Eur J Med Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ejmech.2017.07.060","volume":"138","author":"Papadopoulou M.V.","year":"2017","unstructured":"Papadopoulou M.V.; Bloomer W.D.; Rosenzweig H.S.; Kaiser M.; The antitrypanosomal and antitubercular activity of some nitro(triazole\/imidazole)-based aromatic amines. Eur J Med Chem  2017,138,1106-1113","journal-title":"Eur J Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejmech.2015.10.034","volume":"106","author":"Olmo F.","year":"2015","unstructured":"Olmo F.; G\u00f3mez-Contreras F.; Navarro P.; Mar\u00edn C.; Yunta M.J.R.; Cano C.; Campayo L.; Mart\u00edn-Oliva D.; Rosales M.J.; S\u00e1nchez-Moreno M.; Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative. Eur J Med Chem  2015,106,106-119","journal-title":"Eur J Med Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00044-017-1838-5","volume":"26","author":"Sadashiva R.","year":"2017","unstructured":"Sadashiva R.; Naral D.; Kudva J.; Shivalingegowda N.; Lokanath N.K.; Pampa K.J.; Synthesis, spectral, biological activity, and crystal structure evaluation of novel pyrazoline derivatives having sulfonamide moiety. Med Chem Res  2017,26(6),1213-1227","journal-title":"Med Chem Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1039\/C5NJ02237A","volume":"40","author":"Harikrishna N.","year":"2016","unstructured":"Harikrishna N.; Isloor A.M.; Ananda K.; Obaid A.; Fun H.K.; Synthesis, and antitubercular and antimicrobial activity of 1\u2032-(4-chlorophenyl)pyrazole containing 3,5-disubstituted pyrazoline derivatives. New J Chem  2016,40(1),73-76","journal-title":"New J Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijtb.2023.01.005","volume":"70","author":"Munnaluri R.K.","year":"2023","unstructured":"Munnaluri R.K.; Chevula J.; Patnam N.; Yamini L.; Manga V.; One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME\/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents. Indian J Tuberc  2023,70(4),451-459","journal-title":"Indian J Tuberc"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejmech.2015.05.048","volume":"100","author":"Pieroni M.","year":"2015","unstructured":"Pieroni M.; Wan B.; Zuliani V.; Franzblau S.G.; Costantino G.; Rivara M.; Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design. Eur J Med Chem  2015,100,44-49","journal-title":"Eur J Med Chem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bmc.2017.11.030","volume":"26","author":"El-wahab H.A.A.A.","year":"2018","unstructured":"El-wahab H.A.A.A.; Accietto M.; Marino L.B.; McLean K.J.; Levy C.W.; Abdel-Rahman H.M.; El-Gendy M.A.; Munro A.W.; Aboraia A.S.; Simons C.; Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics. Bioorg Med Chem  2018,26(1),161-176","journal-title":"Bioorg Med Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/open.201900227","volume":"8","author":"Kishk S.M.","year":"2019","unstructured":"Kishk S.M.; McLean K.J.; Sood S.; Smith D.; Evans J.W.D.; Helal M.A.; Gomaa M.S.; Salama I.; Mostafa S.M.; de Carvalho L.P.S.; Levy C.W.; Munro A.W.; Simons C.; Design and synthesis of imidazole and triazole pyrazoles as Mycobacterium tuberculosis CYP121A1 inhibitors. ChemistryOpen  2019,8(7),995-1011","journal-title":"ChemistryOpen"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/2314808X.2023.2185994","volume":"10","author":"Ejeh S.","year":"2023","unstructured":"Ejeh S.; Uzairu A.; Shallangwa G.A.; Abechi S.E.; Ibrahim M.T.; Pharmacoinformatics-based strategy in designing and profiling of some Pyrazole analogues as novel hepatitis C virus inhibitors with pharmacokinetic analysis. Egyptian J Basic Appl Sci  2023,10(1),240-254","journal-title":"Egyptian J Basic Appl Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejmech.2017.09.060","volume":"141","author":"Fioravanti R.","year":"2017","unstructured":"Fioravanti R.; Desideri N.; Carta A.; Atzori E.M.; Delogu I.; Collu G.; Loddo R.; Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. Eur J Med Chem  2017,141,15-25","journal-title":"Eur J Med Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"129080","DOI":"10.1016\/j.bmcl.2022.129080","volume":"79","author":"Nikitina P.A.","year":"2023","unstructured":"Nikitina P.A.; Basanova E.I.; Nikolaenkova E.B.; Os\u2019kina I.A.; Serova O.A.; Bormotov N.I.; Shishkina L.N.; Perevalov V.P.; Tikhonov A.Y.; Synthesis of esters and amides of 2-aryl-1-hydroxy-4-methyl-1H-imidazole-5-carboxylic acids and study of their antiviral activity against orthopoxviruses. Bioorg Med Chem Lett  2023,79,129080","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bmcl.2019.05.019","volume":"29","author":"Hu Y.","year":"2019","unstructured":"Hu Y.; Chen W.; Shen Y.; Zhu B.; Wang G.X.; Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus. Bioorg Med Chem Lett  2019,29(14),1749-1755","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ejmech.2015.12.013","volume":"108","author":"Dong J.","year":"2016","unstructured":"Dong J.; Chen S.; Li R.; Cui W.; Jiang H.; Ling Y.; Yang Z.; Hu W.; Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. Eur J Med Chem  2016,108,605-615","journal-title":"Eur J Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.bmc.2019.04.015","volume":"27","author":"Okano Y.","year":"2019","unstructured":"Okano Y.; Saito-Tarashima N.; Kurosawa M.; Iwabu A.; Ota M.; Watanabe T.; Kato F.; Hishiki T.; Fujimuro M.; Minakawa N.; Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents. Bioorg Med Chem  2019,27(11),2181-2186","journal-title":"Bioorg Med Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejmech.2016.02.016","volume":"112","author":"Karad S.C.","year":"2016","unstructured":"Karad S.C.; Purohit V.B.; Thakor P.; Thakkar V.R.; Raval D.K.; Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities. Eur J Med Chem  2016,112,270-279","journal-title":"Eur J Med Chem"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673301266240506083014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230262\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673301266240506083014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:44:56Z","timestamp":1761547496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230262\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":147,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673301266240506083014","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}